Another study showed that the dominant negative mutant of RhoC significantly reduces the actin polymerization induced by myosin-interacting guanine nucleotide exchange factor (MyoGEF), and inhibits the polarity and invasive activity of breast cancer cells [94]. The gene discussed is RHOC; the disease is breast carcinoma.